Please assess the completion status of the following clinical trial:

Trial Title: Effects of Pomegranate Extract on Intestinal Flora

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 20-50 years of age at screen.~2. In good health~3. Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.~Exclusion Criteria:~1. Any history of gastrointestinal disease except for appendectomy~2. Any use of antibiotics or laxatives during the 2 months prior to study enrollment.~3. Any subject with a history of diabetes mellitus, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP\>160mmHg, diastolic BP\>95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history or routine physical examination.~4. Any subject consuming pre- or probiotics~5. Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.~6. Any subject who currently uses tobacco products or has used tobacco products within the last year.~7. Any subject who is unable or unwilling to comply with the study protocol.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- urolithin excretors (Type: ACTIVE_COMPARATOR): The excretor status will be determined by analysis for urolithin A glucuronide in 24 hour urine after one dose of POMx. A blood sample and stool sample will be obtained before administering the extract.
- non excretors (Type: ACTIVE_COMPARATOR): The excretor status will be determined by analysis for urolithin A glucuronide in 24 hour urine after one dose of POMx. A blood sample and stool sample will be obtained before administering the extract.

Based on this trial design, predict the completion outcome and termination type (if applicable).